Tuesday, 7th February 2012.

Posted on Tuesday, 22nd December 2009 by admin

Pharmaceutical companies are being forced to cut the price of high cost cancer drugs for the first time as a result of a tough new approach by the NHS medicines watchdog, the National Institute for Clinical Excellence (Nice). In the latest example, Nice has today announced approval of trabectedin, a drug for soft tissue sarcoma, [...]

Tags: , , , , ,
Posted in News | Comments (0)

Posted on Saturday, 27th December 2008 by admin

The drugs watchdog Nice is to change the way it makes decisions on NHS treatments, bringing to an end decisions on care of terminally ill patients made solely on cost-efficiency grounds. The National Institute for Health and Clinical Excellence announced yesterday it would be setting out new drug approval guidelines for “less common” illnesses on [...]

Tags: , , ,
Posted in News | Comments (0)

About Privacy Sitemap